Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by Montevialeon Sep 12, 2017 6:13pm

234 Views

Post# 26687340

RE:CGCs new greenhouse compared to Phase III

GoBlue,

Let me see if I have this right. If the numbers below are correct, Aphria will able to produce 2.5 times the yield per square foot compared to Canopy.

Both Aphria and Canopy have plans to expand their respective greenhouses to one million square feet. However, Aphria is projecting 100,000 KG production while Canopy is projecting 40,000 KG.

Why the big discrepency in yield?

Maybe there is merit behind the IP licensing agreements that Aphria has entered into with Copperstate, Liberty Health Sciences, Nuuvera and possibly Ohio (Schottenstein) should they be granted a cultivation License.

M

GoBlue2016 wrote:

CGC. Aph

Cost millions. $34.0 $24.5

Sqft. Production. 250,000. 200,000

Sqft Infrastructure. ?? 55,000

Annual Yield KG 10,000. 20,000

Source material

https://www.reuters.com/article/us-canopy-growth-cannabis/canadas-top-marijuana-producer-to-double-production-idUSKCN1BI2Y1

Slide 10
https://aphria.ca/wp-content/uploads/2017/01/Q4_2017_Aphria_InvestorDeck_PIXELATED.pdf

GoBlue